Enliven Therapeutics, Inc.
ELVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001672619
In the last 90 days, Enliven Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 214 institutions reported holding it in 13F filings for Q2 2026, worth $4.06B in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Enliven Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 122
- +9 vs. Q4 2024
- Shares held
- 49.9M
- +366.0K (+0.7%) vs. Q4 2024
- Total value
- $983.9M
- −$130.3M (−11.7%) vs. Q4 2024
- New holders
- 22
- 42 more added
- Sold out
- 13
- 35 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $4.06B |
| Q1 2026 | 171 | $2.43B |
| Q4 2025 | 126 | $960.9M |
| Q3 2025 | 134 | $1.22B |
| Q2 2025 | 125 | $1.19B |
| Q1 2025 | 122 | $983.9M |
| Q4 2024 | 114 | $1.12B |
| Q3 2024 | 102 | $1.22B |
| Q2 2024 | 93 | $1.13B |
| Q1 2024 | 74 | $780.8M |
| Q4 2023 | 62 | $539.8M |
| Q3 2023 | 61 | $533.8M |
| Q2 2023 | 63 | $797.9M |
| Q1 2023 | 45 | $735.0M |
| Q4 2022 | 36 | $74.7M |
| Q3 2022 | 31 | $18.8M |
| Q2 2022 | 26 | $13.1M |
| Q1 2022 | 31 | $26.2M |
| Q4 2021 | 35 | $33.6M |
| Q3 2021 | 38 | $62.5M |
| Q2 2021 | 31 | $86.3M |
| Q1 2021 | 40 | $92.9M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Enliven Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Northern Trust Corp | 338,650 | $6.66M | 0.00% | +7,150+2.2% | Added |
| Adage Capital Partners GP, L.L.C. | 450,000 | $8.86M | 0.02% | −200,000−30.8% | Reduced |
| Rock Springs Capital Management LP | 465,871 | $9.17M | 0.52% | +37,300+8.7% | Added |
| First Turn Management, LLC | 535,092 | $10.5M | 2.12% | 00.0% | Unchanged |
| Boxer Capital Management, LLC | 671,358 | $13.2M | 3.97% | 00.0% | Unchanged |
| Blackstone Group Inc. | 762,307 | $15.0M | 0.07% | +388,984+104.2% | Added |
| State Street Corp | 780,902 | $15.4M | 0.00% | −20,930−2.6% | Reduced |
| Woodline Partners LP | 805,157 | $15.8M | 0.10% | −765−0.1% | Reduced |
| Geode Capital Management, LLC | 819,173 | $16.1M | 0.00% | +56,455+7.4% | Added |
| Ra Capital Management, L.P. | 848,986 | $16.7M | 0.28% | 00.0% | Unchanged |
| Pictet Asset Management Holding SA | 967,502 | $19.0M | 0.02% | −4,791−0.5% | Reduced |
| Citadel Advisors LLC | 1,123,138 | $22.1M | 0.02% | −615,394−35.4% | Reduced |
| 5AM Venture Management, LLC | 1,322,477 | $26.0M | 9.84% | −307,288−18.9% | Reduced |
| Janus Henderson Group PLC | 1,570,503 | $33.1M | 0.02% | +238,626+17.9% | Added |
| Vanguard Group Inc | 1,972,239 | $38.8M | 0.00% | −3,416−0.2% | Reduced |
| Polar Capital Holdings Plc | 2,365,294 | $46.5M | 0.29% | −24,374−1.0% | Reduced |
| BlackRock, Inc. | 2,998,129 | $59.0M | 0.00% | +33,001+1.1% | Added |
| Fairmount Funds Management LLC | 3,202,798 | $63.0M | 9.78% | 00.0% | Unchanged |
| VR Adviser, LLC | 4,026,331 | $79.2M | 6.74% | 00.0% | Unchanged |
| Commodore Capital LP | 4,675,000 | $92.0M | 6.78% | +470,000+11.2% | Added |
| FMR LLC | 6,609,529 | $130.1M | 0.01% | +113,658+1.7% | Added |
| OrbiMed Advisors LLC | 7,959,538 | $156.6M | 3.76% | 00.0% | Unchanged |
| Nicholas Investment Partners, LP | 0 | $0 | 0.00% | −157,635−100.0% | Sold out |
| Artia Global Partners LP | 0 | $0 | 0.00% | −102,900−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −75,405−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −24,887−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −14,620−100.0% | Sold out |
| Legato Capital Management LLC | 0 | $0 | 0.00% | −13,492−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −10,702−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −10,144−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −3,091−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −650−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −302−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −103−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |